Skip to main content
. 2013 Feb 4;171(3):247–254. doi: 10.1111/cei.12026

Figure 1.

Figure 1

Serum glutamic acid decarboxylase antibody (GADA) titres (U/ml) in stiff-person syndrome (SPS) (circles, n = 12), type 1 diabetes mellitus (T1D) (squares, n = 7), glutamic acid decarboxylase (GAD)-alum (rhombuses, n = 9) and high-risk (triangles, n = 6) groups. Empty circles in the SPS group (n = 8) represent individuals with co-existent T1D, whereas empty triangles in the high-risk group (n = 3) represent individuals who developed T1D after sampling. Significant differences are indicated as P-values and horizontal lines represent the median.